All Stories

  1. Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochromebc1Inhibition Strategy for Malaria

    Article • Antimicrobial Agents and Chemotherapy, June 2016, ASM Journals

    Michael Riscoe

  2. ELQ-300 Prodrugs for Enhanced Delivery and Single-Dose Cure of Malaria

    Article • Antimicrobial Agents and Chemotherapy, June 2015, ASM Journals

    Michael Riscoe

  3. Subtle Changes in Endochin-Like Quinolone Structure Alter the Site of Inhibition within the Cytochromebc1Complex of Plasmodium falciparum

    Article • Antimicrobial Agents and Chemotherapy, January 2015, ASM Journals

    Michael Riscoe, Professor David A Fidock